0001209191-21-069130.txt : 20211210
0001209191-21-069130.hdr.sgml : 20211210
20211210192000
ACCESSION NUMBER: 0001209191-21-069130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211208
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULIMAN SHEHNAAZ
CENTRAL INDEX KEY: 0001713070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38792
FILM NUMBER: 211486640
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alector, Inc.
CENTRAL INDEX KEY: 0001653087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822933343
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 OYSTER POINT BLVD., SUITE 600
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-231-5660
MAIL ADDRESS:
STREET 1: 131 OYSTER POINT BLVD., SUITE 600
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Alector LLC
DATE OF NAME CHANGE: 20150915
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-08
0
0001653087
Alector, Inc.
ALEC
0001713070
SULIMAN SHEHNAAZ
C/O ALECTOR, INC.
131 OYSTER POINT BLVD, SUITE 600
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
President and COO
Common Stock
2021-12-08
4
M
0
19813
17.23
A
122411
D
Common Stock
2021-12-08
4
M
0
55187
10.24
A
177598
D
Common Stock
2021-12-08
4
S
0
36511
22.5583
D
141087
D
Common Stock
2021-12-08
4
S
0
38489
23.0115
D
102598
D
Common Stock
2021-12-09
4
M
0
75000
17.23
A
177598
D
Common Stock
2021-12-09
4
S
0
72357
22.8034
D
105241
D
Common Stock
2021-12-09
4
S
0
2643
23.4043
D
102598
D
Employee Stock Option (right to buy)
17.23
2021-12-08
4
M
0
19813
0.00
D
2029-12-31
Common Stock
19813
530187
D
Employee Stock Option (right to buy)
10.24
2021-12-08
4
M
0
55187
0.00
D
2030-09-30
Common Stock
55187
134026
D
Employee Stock Option (right to buy)
17.23
2021-12-09
4
M
0
75000
0.00
D
2029-12-31
Common Stock
75000
455187
D
Includes 755 shares acquired on December 1, 2020 and 1,843 shares acquired on June 1, 2021 pursuant to the Issuer's employee stock purchase plan.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.94 to $22.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.94 to $23.10, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.36 to $23.35, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.36 to $23.44, inclusive.
One-fourth of the shares subject to the option grant vested on December 9, 2020, and 1/48th vest monthly thereafter.
The shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2020.
/s/ David Oh, by power of attorney
2021-12-10